Mesoblast (MESO) Net Cash Flow (QoQ) (2016 - 2023)
Mesoblast (MESO) Net Cash Flow (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 219.88% |
| Mar 31, 2023 | -1.43% |
| Dec 31, 2022 | -171.68% |
| Sep 30, 2022 | 259.73% |
| Jun 30, 2022 | 10.72% |
| Mar 31, 2022 | 14.56% |
| Dec 31, 2021 | -3.59% |
| Sep 30, 2021 | 4.36% |
| Jun 30, 2021 | -126.41% |
| Mar 31, 2021 | 355.13% |
| Dec 31, 2020 | -46.19% |
| Sep 30, 2020 | -40.01% |
| Jun 30, 2020 | 24.70% |
| Mar 31, 2020 | -1,050.81% |
| Dec 31, 2019 | 88.69% |
| Sep 30, 2019 | 20.48% |
| Jun 30, 2019 | 6.56% |
| Mar 31, 2019 | -1,187.88% |
| Dec 31, 2018 | 109.99% |
| Sep 30, 2018 | 5.05% |